Results 131 to 140 of about 142,321 (206)

Real-world lymphoma cohort in an HIV-endemic setting: cohort design, epidemiological features and impact of implementing novel classification standards. [PDF]

BMC Cancer
Andera LF, Chetty DR, Mohamed Z, Oelofse D, Bailey J, Brown K, Panchoo G, Antel K, Simba K, Kritzinger G, Cassim S, Ramburan A, Opie JJ, Louw VJ, Verburgh E.   +14 more
europepmc   +1 more source

Utility of dual assessment of cyTRBC1 and cyTRBC2 by flow cytometry for identifying clonality in sCD3-negative to dimly expressing T cells. [PDF]

Blood Cancer J
Li M, Fu J, Li Y, Fan X, Zhang L, Zhou L, Zhang J, Zhang J, Xi Q.   +8 more
europepmc   +1 more source

Splenic B-Cell Lymphoma/Leukemia With Prominent Nucleoli Presenting With Characteristic Peripheral Blood and Bone Marrow Findings. [PDF]

EJHaem
Son K, Shimomura Y, Yamashita D, Kondo T.   +3 more
europepmc   +1 more source

Temporal bone mass as the initial presentation of peripheral T-cell lymphoma in an infant: a case report. [PDF]

BMC Pediatr
Forero-Sanchez AS, Yepes-Madrid N, Gómez-Urrego JF, Segura-Galvis RA, Caicedo-Estrada CA.   +4 more
europepmc   +1 more source

Flow Cytometry for Diagnosing Sézary Syndrome When Skin Biopsies Are Inconclusive: A Case Report. [PDF]

Cureus
El Mrahi A, Denna S, Bensalah M, Nassiba Z, Zizi N.   +4 more
europepmc   +1 more source

Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma. [PDF]

Acta Derm Venereol
Samaran Q, Duboëlle M, Marque A, Bres V, Dereure O.   +4 more
europepmc   +1 more source

Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting. [PDF]

Hemasphere
Antel K, Xiong N, Merrill M, Chen T, McGrath L, Droessler C, van der Schyff M, Wu MX, Cheddie D, Slome C, McBride L, Day J, Mohamed Z, Fakie N, Mbatani N, Shultz C, Meintjes G, Tyekucheva S, Cohen EF, Tolstorukov MY, Verburgh E, Murakami MA.   +21 more
europepmc   +1 more source

Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus. [PDF]

Lupus Sci Med
Martins E, Chindalore VL, Sheng XR, Schroeder AV, Chen V, Mody H, Arjomandi A, Mao HA, Hassan I, Dankiewicz-Fares I, Agachi S, Omachi TA, Garg JP, Pendergraft WF.   +13 more
europepmc   +1 more source

Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy. [PDF]

Blood Adv
Xu R, Wu G, Rice S, Booker M, Weekes J, Bell H, Gao Y, Nirmal AJ, Liu H, Ciantra Z, Luo Q, Fortune A, Whalen K, Guanci T, Wan Y, Louissaint A, Nordberg JJ, Lin JR, Hemann M, Manalis SR, Armand P, Smith E, Jacobson CA, Tolstorukov M, Murakami MA, Sorger PK, Weinstock DM, Song L, Lane AA.   +28 more
europepmc   +1 more source

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery. [PDF]

Radiol Oncol
Jurca T, Boltezar L, Orazem M, Komlos KF, Pohar K, Jevnikar S, Poljak M, Mastnak DM, Kozjek NR, Vratanar B, Ocvirk J, Ihan A.   +11 more
europepmc   +1 more source